257 related articles for article (PubMed ID: 34623609)
41. Knockdown of circ_0003928 ameliorates high glucose-induced dysfunction of human tubular epithelial cells through the miR-506-3p/HDAC4 pathway in diabetic nephropathy.
Liu Q; Cui Y; Ding N; Zhou C
Eur J Med Res; 2022 Apr; 27(1):55. PubMed ID: 35392987
[TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis.
Yang J; Wu L; Liu S; Hu X; Wang Q; Fang L
Med Microbiol Immunol; 2021 Jun; 210(2-3):121-132. PubMed ID: 33885954
[TBL] [Abstract][Full Text] [Related]
43. LncRNA TCF7 contributes to high glucose-induced damage in human podocytes by up-regulating SEMA3A via sponging miR-16-5p.
Jiang Z; Qian L; Yang R; Wu Y; Guo Y; Chen T
J Diabetes Investig; 2023 Feb; 14(2):193-204. PubMed ID: 36583231
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA CACNA1G-AS1 promotes proliferation and invasion and inhibits apoptosis by regulating expression of miR-205 in human keloid fibroblasts.
Zhao X; Jie X; Gao YK; Nie B; Jiang H
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32495824
[TBL] [Abstract][Full Text] [Related]
45. LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis.
Gu E; Pan W; Chen K; Zheng Z; Chen G; Cai P
J Mol Neurosci; 2021 Jun; 71(6):1256-1265. PubMed ID: 33205379
[TBL] [Abstract][Full Text] [Related]
46. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
47. LncRNA MALAT1 Aggravates Renal Tubular Injury
Song P; Chen Y; Liu Z; Liu H; Xiao L; Sun L; Wei J; He L
Front Endocrinol (Lausanne); 2022; 13():895360. PubMed ID: 35813614
[TBL] [Abstract][Full Text] [Related]
48. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
Sun H; Wang C; Zhou Y; Cheng X
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
[TBL] [Abstract][Full Text] [Related]
49. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
50. Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis.
Zhang M; Zhao S; Xu C; Shen Y; Huang J; Shen S; Li Y; Chen X
Biochem Biophys Res Commun; 2020 Dec; 533(3):429-436. PubMed ID: 32972755
[TBL] [Abstract][Full Text] [Related]
51. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
Liu B; Qiang L; Wang GD; Duan Q; Liu J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
[TBL] [Abstract][Full Text] [Related]
52. Depression of LncRNA DANCR alleviates tubular injury in diabetic nephropathy by regulating KLF5 through sponge miR-214-5p.
Kuang Y; Yang J; Sun M; Rui T; Yang Z; Shi M
BMC Nephrol; 2024 Apr; 25(1):130. PubMed ID: 38609873
[TBL] [Abstract][Full Text] [Related]
53. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.
Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y
Bioengineered; 2022 Jan; 13(1):634-644. PubMed ID: 34898373
[TBL] [Abstract][Full Text] [Related]
55. LncRNA JHDM1D-AS1 Suppresses MPP + -Induced Neuronal Injury in Parkinson's Disease via miR-134-5p/PIK3R3 Axis.
Wang C; Zhang H; Li J
Neurotox Res; 2021 Dec; 39(6):1771-1781. PubMed ID: 34773593
[TBL] [Abstract][Full Text] [Related]
56. LncRNA ZEB1-AS1 inhibits renal fibrosis in diabetic nephropathy by regulating the miR-217/MAFB axis.
Song Y; Miao C; Wang J
RSC Adv; 2019 Sep; 9(52):30389-30397. PubMed ID: 35557748
[TBL] [Abstract][Full Text] [Related]
57. MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.
Zhao N; Luo Q; Lin R; Li Q; Ma P
Clin Exp Nephrol; 2021 Nov; 25(11):1182-1192. PubMed ID: 34145485
[TBL] [Abstract][Full Text] [Related]
58. MiR-1297 attenuates high glucose-induced injury in HK-2 cells via targeting COL1A2.
Wang S; Sun K; Hu H; Jin X; Wang Z; Zhang H; Zhao X
Nephrology (Carlton); 2021 Jul; 26(7):623-631. PubMed ID: 33811432
[TBL] [Abstract][Full Text] [Related]
59. Knockdown of Long Non-Coding RNA RP11-445H22.4 Alleviates LPS-Induced Injuries by Regulation of MiR-301a in Osteoarthritis.
Sun T; Yu J; Han L; Tian S; Xu B; Gong X; Zhao Q; Wang Y
Cell Physiol Biochem; 2018; 45(2):832-843. PubMed ID: 29414810
[TBL] [Abstract][Full Text] [Related]
60. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
